Le Lézard
Classified in: Health
Subjects: HSP, FVT

Interview with Erika Ender, co-author of "Despacito"; disruptive innovation and personal brand. Wrapping up the year on Ismael Cala's podcast


Gaby CastellanosIsra García and Ulises Bacilio-Pérez complete the guest list. The podcast is available for free each week on the platform http://www.revolverpodcasts.com/shows/dmente-positivo-con-ismael-cala/

MIAMI, Dec. 4, 2018 /PRNewswire/ -- Ismael Cala, life and business strategist, lecturer and author of eight bestsellers on themes of leadership and emotional intelligence, is presenting four new programs in December on his podcast dMENTE Positivo. This space on awakening consciousness and personal growth will conclude 2018 with an interview with Erika Ender, award-winning co-author of the tune Despacito ('Easy does it').

December will feature the following guests and themes:

Tuesday, December 4 : Guest: Isra García.  Marketing expert. Coach, writer, educator and blogger on issues of disruptive innovation, high yield digital transformation and experimental lifestyles. An indefatigable person who is always looking for ways to challenge himself.

Tuesday, December 11 : Guest: Gaby Castellanos. Venezuelan by birth, Spanish by adoption. Foul-mouthed, sincere and direct, she doesn't leave anyone cold. She is irreverence in person! A specialist in digital marketing and personal brand issues. Currently heading her most ambitious project to date: socialphilia-karma advertising, with offices in Madrid, Buenos Aires, Caracas and Miami.

Tuesday, December 18 : Guest: Dr. Ulises Bacilio-Pérez. A Mexican physician and specialist in radiology. A visionary and entrepreneur, who has rethought social and health care structures with innovative projects based on pioneering technologies such as cryptocurrency mechanisms.

Tuesday, December 25 : Guest: Erika Ender.  Panamanian singer-songwriter of Brazilian and U.S. ancestry, globally recognized as the co-author, first with Luis Fonsi, of the tune "Despacito." Among her personal credits, Erika has composed major international hits such  as Candela ('Candle'), interpreted by Chayanne, and A puro dolor ('Purest of pain'),  by the group Son by four.

In this last month of the year, Ismael Cala, joined by Lorena Susso and Moe Morales will be bringing us four programs full of information and recommendations on the dMENTE Positivo podcast, distributed for free on the reVolver platform: http://www.revolverpodcasts.com/shows/dmente-positivo-con-ismael-cala/

It is simultaneously available for download on Apple, Podcast, Google Play and Spotify.

ABOUT ISMAEL CALA

A life and business strategist, for five and a half years Ismael Cala was the host of CALA during prime time on CNN en Espańol.  A businessman and social entrepreneur. Author of eight bestsellers on themes of leadership, entrepreneurship and personal development, including El poder de escuchar ('The power of listening'), and Despierta con Cala ('Wake up with Cala'). Cala was born in Santiago de Cuba in 1969, and holds a degree in Art History from Oriente University.  He is the co-author of the book "Beat the Curve," with Brian Tracy.  He graduated from the School of Communication at York University in Toronto, and has a diploma from Seneca College in Television Production. He is President and founder of the Cala Enterprises Corporation and the Ismael Cala Foundation

SOURCE Cala Enterprises


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: